Sun Pharmaceutical issued a voluntary recall of lisdexamfetamine dimesylate capsules, used for attention ...

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in ...

Nearly 19 million children in the United States have at least one parent with a substance use disorder, according to a new study published Monday in JAMA Pediatrics. And a significant number of those ...

How political red tape and a drug company’s thirst for profits limited the reach of a drug that experts believe could have reduced the opioid epidemic’s toll. Credit...Photo illustration by Ben Denzer ...

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction, according to a new paper published in the Journal of the Endocrine ...

Every day, drug and alcohol addiction shatters families, destabilizes neighborhoods, derails careers, and steals the lives of countless Americans. This National Alcohol and Drug Addiction Recovery ...

Aug 27 (Reuters) - BioXcel Therapeutics (BTAI.O), opens new tab said on Wednesday it plans to seek expanded approval early next year for use of its agitation drug at home after it succeeded in a ...